Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands
Henry, Thea L, De Brouwer, Bonnie F E, Van Keep, Marjolijn M L, Blankestijn, Peter J, Bots, Michiel L, Koffijberg, Hendrik
Published in Journal of medical economics (01.01.2015)
Published in Journal of medical economics (01.01.2015)
Get more information
Journal Article
Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model
Schurer, Marieke, Patel, Renu, van Keep, Marjolijn, Horgan, Jake, Matthijsse, Suzette, Madin-Warburton, Matthew
Published in Frontiers in medical technology (13.02.2023)
Published in Frontiers in medical technology (13.02.2023)
Get full text
Journal Article
A new modeling approach allowing prediction and comparison of the long-term outcomes of treatments for hemophilia B
Keep, Marjolijn van, Hoxer, Christina Stentoft, Hemstock, Matthew, Groth, Andreas Velsing, Knight, Christopher
Published in Journal of comparative effectiveness research (01.01.2018)
Published in Journal of comparative effectiveness research (01.01.2018)
Get full text
Journal Article
Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?
Urbanus, Anouk T, van Keep, Marjolijn, Matser, Amy A, Rozenbaum, Mark H, Weegink, Christine J, van den Hoek, Anneke, Prins, Maria, Postma, Maarten J
Published in PloS one (12.08.2013)
Published in PloS one (12.08.2013)
Get full text
Journal Article
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective
Mehra, Ranee, Yong, Candice, Seal, Brian, van Keep, Marjolijn, Raad, Angie, Zhang, Yiduo
Published in Journal of the National Comprehensive Cancer Network (01.02.2021)
Published in Journal of the National Comprehensive Cancer Network (01.02.2021)
Get more information
Journal Article
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands
Schurer, Marieke, Matthijsse, Suzette M., Vossen, Carla Y., van Keep, Marjolijn, Horscroft, James, Chapman, Ann-Marie, Akehurst, Ron L.
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Emery, Paul, Van Keep, Marjolijn, Beard, Steve, Graham, Chris, Miles, LaStella, Jugl, Steffen Marc, Gunda, Praveen, Halliday, Anna, Marzo-Ortega, Helena
Published in PharmacoEconomics (01.08.2018)
Published in PharmacoEconomics (01.08.2018)
Get full text
Journal Article
108. THE COST-EFFECTIVENESS OF SECUKINUMAB VERSUS TUMOUR NECROSIS FACTOR α INHIBITOR BIOSIMILARS FOR ANKYLOSING SPONDYLITIS IN THE UK
Marzo-Ortega, Helena, Halliday, Anna, Jugl, Steffen, Mokashi, Soniya, Gunda, Praveen, Graham, Chris, Miles, LaStella, Beard, Steve, van Keep, Marjolijn
Published in Rheumatology (Oxford, England) (01.04.2017)
Published in Rheumatology (Oxford, England) (01.04.2017)
Get full text
Journal Article
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
Taylor, Rod S., Bentley, Anthony, Metcalfe, Kaylie, Lobo, Melvin D., Kirtane, Ajay J., Azizi, Michel, Clark, Christopher, Murphy, Kieran, Boer, Jennifer H., van Keep, Marjolijn, Ta, An Thu, Barman, Neil C., Schwab, Garrett, Akehurst, Ron, Schmieder, Roland E.
Published in PharmacoEconomics - open (01.07.2024)
Published in PharmacoEconomics - open (01.07.2024)
Get full text
Journal Article
Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
Taylor, Rod S., Bentley, Anthony, Metcalfe, Kaylie, Lobo, Melvin D., Kirtane, Ajay J., Azizi, Michel, Clark, Christopher, Murphy, Kieran, Boer, Jennifer H., van Keep, Marjolijn, Ta, An Thu, Barman, Neil C., Schwab, Garrett, Akehurst, Ron, Schmieder, Roland E.
Published in PharmacoEconomics - open (01.07.2024)
Published in PharmacoEconomics - open (01.07.2024)
Get full text
Journal Article
Cost Effectiveness of Durvalumab in Unresectable Stage III NSCLC: 4-Year Survival Update and Model Validation from a UK Healthcare Perspective
Dunlop, Will, van Keep, Marjolijn, Elroy, Peter, Perez, Ignacio Diaz, Ouwens, Mario J. N. M., Sarbajna, Tina, Zhang, Yiduo, Greystoke, Alastair
Published in PharmacoEconomics - open (01.03.2022)
Published in PharmacoEconomics - open (01.03.2022)
Get full text
Journal Article